Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors

NCT07358806 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Breast Cancer
Head and Neck Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Gastric/Gastroesophageal Junction Cancer

Interventions

DRUG: OCT-598
COMBINATION_PRODUCT: Docetaxel

Sponsor

Oscotec Inc.